AZ Phoenix의 과체중 임상 시험
과체중 관련 연구 15개가 Phoenix 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
피험자 모집 중3상
- Absolute Clinical Research, Phoenix
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
피험자 모집 중3상
- RIO Clinical Trials - Phoenix, Phoenix
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
피험자 모집 중3상
- Research Site, Phoenix
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
피험자 모집 중3상
- Elite Clinical Studies, LLC, Phoenix
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
피험자 모집 중3상
- Synexus Clinical Research US, Inc., Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
피험자 모집 중3상
- AURORA-1 Clinical Site, Phoenix
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
피험자 모집 중3상
- AURORA-2 Clinical Site, Phoenix
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
피험자 모집 중2상
- Helios Clinical Research - Phoenix, Phoenix
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
피험자 모집 중3상건강한 지원자 환영
- ACCOMPLISH-2 Research Site, Phoenix
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
피험자 모집 중2상
- Synexus Clinical Research US, Inc., Phoenix
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
피험자 모집 중4상
- Medical Dermatology Specialists, Phoenix
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
피험자 모집 중3상
- Kailera Clinical Site, Phoenix
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
피험자 모집 중관찰 연구
- Exponent Phoenix, Phoenix
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
피험자 모집 중3상
- ACCOMPLISH-1 Research Site, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
피험자 모집 중3상
- The University of Arizona College of Medicine- Phoenix, Phoenix
다른 도시의 과체중 시험
- Houston, TX연구 33개
- San Antonio, TX연구 33개
- Chicago, IL연구 28개
- Orlando, FL연구 25개
- Las Vegas, NV연구 23개
- Miami, FL연구 23개
- Dallas, TX연구 20개
- Atlanta, GA연구 20개
- Jacksonville, FL연구 19개
- Washington, DC연구 19개
- New York City, NY연구 19개
- Austin, TX연구 18개
Phoenix의 다른 연구
- 유방암연구 25개
- 대장직장암연구 25개
- 비만연구 23개
- 비소세포폐암연구 21개
- 전이성 암연구 20개
- 암 (전체)연구 18개
- 심부전연구 18개
- 전립선암연구 17개
- 췌장암연구 17개
- 심혈관 질환연구 16개
- 다발성 골수종연구 16개
- 알츠하이머병연구 15개
ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.